Korea’s MFDS completes inspection at Concord Biotech's Dholka unit
Drug Approval

Korea’s MFDS completes inspection at Concord Biotech's Dholka unit

The inspection was successfully completed

  • By IPP Bureau | February 21, 2025

The Ministry of Food and Drug Safety (MFDS) (formerly the Korea Food and Drug Administration (KFDA) has conducted an inspection at Company's Manufacturing Unit I, (API facility), located at Dholka, Gujarat from Tuesday, 18th February, 2025 to Thursday 20th February, 2025.

The inspection was successfully completed. This achievement underscores our unwavering commitment to maintain world-class quality systems and standards.

Upcoming E-conference

Other Related stories

Startup

Digitization